Holen Sie sich die Stockscreener-App
0.3799
3.38%
-0.0133
Schlusskurs vom Vortag:
$0.3932
Offen:
$0.393
24-Stunden-Volumen:
176.39K
Relative Volume:
0.38
Marktkapitalisierung:
$25.47M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-126.61M
KGV:
-0.1938
EPS:
-1.96
Netto-Cashflow:
$-60.14M
1W Leistung:
+1.14%
1M Leistung:
-7.23%
6M Leistung:
-72.27%
1J Leistung:
-88.73%
1-Tages-Spanne:
$0.3777
$0.406
1-Wochen-Bereich:
$0.362
$0.407
52-Wochen-Spanne:
$0.316
$3.65
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Vergleichen Sie GBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.3799 | 25.18M | 0 | -126.61M | -60.14M | -1.96 |
|
ONC
Beigene Ltd Adr
|
238.76 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.03 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.85 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.69 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-19 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-07 | Eingeleitet | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Dimensional Fund Advisors LP Has $420,000 Stock Holdings in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Layoff Tracker: Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs - BioSpace
Wedbush Issues Negative Forecast for Generation Bio Earnings - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Generation Bio (NASDAQ:GBIO) - Defense World
Generation Bio Co (GBIO)’s Market Momentum: Closing Strong at 0.48, Down -6.25 - DWinneX
Generation Bio Co. Reports Reduced Losses and Increased Revenue - TipRanks
Where Generation Bio Stands With Analysts - Benzinga
Needham Reiterates Buy Rating for Generation Bio (GBIO) | GBIO Stock News - GuruFocus
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - The Manila Times
Generation Bio earnings beat by $0.08, revenue topped estimates - Investing.com
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Metric Deep Dive: Understanding Generation Bio Co (GBIO) Through its Ratios - DWinneX
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Renaissance Technologies LLC Has $1.02 Million Stock Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Revolutionary Green Innovation: Braskem's Bio-Based Polyethylene Transforms Nonwovens Industry - Stock Titan
Generation Bio Co [GBIO] stock for 120,759 USD was acquired by Quinn Anthony G. - knoxdaily.com
GBIO’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Generation Bio Co (GBIO) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Generation Bio Insiders Recover Some Losses, Which Stand At US$115k - simplywall.st
Generation Bio Co (NASDAQ: GBIO) Stock Is A Good Option To Consider - Stocksregister
Next-Generation Biomanufacturing Market Current Scenario with Future Trends Analysis to 2031 - openPR.com
Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World
GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia
GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa
LG Innotek, KAIST collaborate for next gen technology - 매일경제
Baker Hughes Co [BKR] Shares Rise 0.27 % on Wednesday - knoxdaily.com
Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times
Generation Bio Takes Center Stage: CEO Fireside Chat at Major Healthcare Conference - Stock Titan
Generation Bio stock hits 52-week low at $0.4 amid steep decline By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Cuts Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates - MSN
Generation Bio stock hits 52-week low at $0.47 By Investing.com - Investing.com South Africa
Generation Bio stock hits 52-week low at $0.47 - Investing.com India
Generation Bio’s (GBIO) Buy Rating Reaffirmed at Canaccord Genuity Group - Defense World
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution By Investing.com - Investing.com South Africa
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution - Investing.com Australia
Generation Bio’s (GBIO) Outperform Rating Reiterated at Wedbush - Defense World
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
6.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):